Plus Therapeutics (XMP0.F) Q1 2025 Earnings

27MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1
-0.78
-0.57
-0.35

Details

Expected EPS
-0.45983417528000003
Actual EPS
-0.3518192
Surprise EPS
0.11
Surprise Percent
+23.49%

Description

Plus Therapeutics (XMP0.F) has reported earnings of -0.3518192 per share for Q1 2025.

0 Comments

Share your thoughts